QUALIFYING CONDITIONS:

• Amyotrophic Lateral Sclerosis (ALS-Lou Gehrig's Disease);

• Autism;

• Cancer, including remission therapy;

• Crohn’s Disease;

• Damage to the nervous tissue of the central nervous system (brain-spinal cord) with objective neurological indication of intractable spasticity, and other associated neuropathies;

• Dyskinetic and spastic movement disorders;

• Epilepsy;

• Glaucoma;

• Human Immunodeficiency Virus (HIV) / Acquired Immune Deficiency Syndrome (AIDS);

• Huntington’s Disease;

• Inflammatory Bowel Disease;

• Intractable Seizures (IS);

• Multiple Sclerosis (MS);

• Neurodegenerative Diseases;

• Neuropathies;

• Opioid use disorder for which conventional therapeutic interventions are contraindicated or ineffective, or for which adjunctive therapy is indicated in combination with primary therapeutic interventions;

• Parkinson's Disease

• Post-traumatic Stress Disorder (PTSD);

• Severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain;

• Sickle Cell Anemia;

• Terminal illness.

• Anxiety

• Tourettes Syndrome

​

​